NCT05133661Active, not recruiting
SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)
Feasibility and Acceptability of Implementing Integrated HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions in Burkina Faso, Côte d'Ivoire, Guatemala, and the Philippines
Source: ClinicalTrials.gov · Last updated 17 Sept 2025
Brief summary (registry, in English)
The goal is to assess the feasibility and acceptability of integrating into existing health systems, provision of HPV screening and treatment of pre-cancerous cervical cancer lesions with ablative treatments in Burkina Faso, Côte d'Ivoire, Guatemala, and the Philippines. Study findings will inform implementation of cervical cancer prevention and treatment services as part of a global effort to eliminate cervical cancer, with particular relevance for low-and-middle income countries. This will inform country strategy and guidelines on offering integrated cervical cancer prevention and treatment services in a manner that is culturally sensitive, client oriented, and system appropriate.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 17602 (estimated)
- First submitted
- 13 Nov 2021
- Start date
- 19 Apr 2022
- Primary completion date
- 5 Sept 2025
- Lead sponsor
- Jhpiego
- Diseases
- Cervical cancer
- NCT number
- NCT05133661
What you commit to
- Study type: Observational
- Planned participants: 17602
- From 19 Apr 2022 to the primary completion date, 5 Sept 2025
- 4 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnant women
- Individuals unwilling to participate or unable to provide informed consent
Who the study is looking for
- Women: Participants will be women residing in the study area, seeking services at SUCCESS project-supported health facilities, and meet the eligibility criteria to be enrolled in one of the components of the study (i.e, prospective component, client exit interviews and/or in-depth interviews).
- Service providers: Health care personnel working in the project facilities at the time of the study providing services related to cervical cancer screening and treatment. Facility in-charges and laboratory personnel are included in this category.
- Key informants: Health program managers, and community mobilizers at either local or national level in Burkina Faso, Cote d'Ivoire, Guatemala, and Philippines.
- Men: Male members of the community (married or cohabiting with female partners) to gather their perspectives on the implementation of the cervical cancer prevention and treatment activities.
Age in the registry: 25 years to 49 years · Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CMA de Do Coordinator of this site? Confirm its status | Ouagadougou | Burkina Faso | Unknown status |
| FSU Koko Coordinator of this site? Confirm its status | Bouaké | Côte d’Ivoire | Unknown status |
| Quetzaltenango Coordinator of this site? Confirm its status | Quetzaltenango | Guatemala | Unknown status |
| Metro-Manila Coordinator of this site? Confirm its status | Quezon City | Philippines | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.